Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith ...

Three of the world’s leading AI companies are racing to go public, opening yet another front in the high-stakes competition ...

In 2001, Thierry Frémaux arrived in Cannes with a mandate: Build a bridge to Hollywood. The newly installed festival director made a pilgrimage to Los Angeles to sell the major studios on the virtues ...

In a strange turn, none of the films slated for this year’s Memorial Day Weekend — the (un)official kickoff of the summer blockbuster rush — actually fit the blockbuster bill, with those more ...

After doubling sales of its Biogen-partnered Alzheimer’s disease med Leqembi in its 2025 fiscal year, Eisai figures the crawl to its blockbuster ambitions will hit a stride in 2026, when it expects to ...

Certain trades are so huge that they changed the course of a sport. Babe Ruth to the Yankees, Wayne Gretzky to the Kings and more recently, Luka Doncic to the Lakers. That's what I think we've got in ...

MMA fans worldwide are counting down the days to Ronda Rousey’s highly anticipated return to the cage, which is just 10 days away. In a headline-making showdown, she will go toe-to-toe with Gina ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

When it comes to GSK’s new dealmaking strategy of trying to outdo established blockbusters, CEO Luke Miels has told Fierce that oncology may offer the most tempting targets. Miels—who served as GSK’s ...

Free speech advocates sounded the alarm Tuesday over the Federal Communications Commission’s challenge to ABC’s broadcast licenses, with some decrying the move as a threat to the First Amendment and a ...

Ari Emanuel (center) could play role in the upcoming Sam Altman-Elon Musk trail. It’s dripping in drama — there’s drugs, sex and plenty of boardroom betrayal among some of the richest people in the ...

A long-awaited trial between Elon Musk and Sam Altman’s OpenAI began in a federal court in Oakland, California on Monday morning. Exactly https://t.co/hd6rx0aF2i ...